The rationale for case-control methodology in epidemiological studies of cancer risk (response to Speirs et al., 1990)

Por Caporaso, N, Idle, J R
Publicado em 1990

Treatment of angina pectoris with nifedipine.

Por Idle, J R, Sever, P S
Publicado em 1983

Protecting the poor metaboliser—from Jack & Wilkins. Dr Idle and Professor Smith reply as follows

Por Idle, J. R., Smith, R. L.
Publicado em 1984

New opportunities in cancer risk evaluation using PCR-based DNA analysis for CYP2D6.

Por Idle, J R, Daly, A K
Publicado em 1993

Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.

Por Daly, A K, Cholerton, S, Armstrong, M, Idle, J R
Publicado em 1994

Oxidation phenotype and metiamide metabolism [proceedings]

Por Idle, J. R., Ritchie, J. C., Smith, R. L.
Publicado em 1979

Application of the phenotyped panel approach to the detection of polymorphism of drug oxidation in man [proceedings]

Por Idle, J. R., Sloan, T. P., Smith, R. L., Wakile, L. A.
Publicado em 1979

The influence of food on the pharmacokinetics of 'biphasic' nifedipine at steady state in normal subjects.

Por Rimoy, G H, Idle, J R, Bhaskar, N K, Rubin, P C
Publicado em 1989

Polymorphism of carbon oxidation of drugs and clinical implications.

Por Sloan, T P, Mahgoub, A, Lancaster, R, Idle, J R, Smith, R L
Publicado em 1978

Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis.

Por Beyeler, C, Armstrong, M, Bird, H A, Idle, J R, Daly, A K
Publicado em 1996

A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population.

Por Evans, D A, Mahgoub, A, Sloan, T P, Idle, J R, Smith, R L
Publicado em 1980

Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine.

Por Edwards, C, Monkman, S, Cholerton, S, Rawlins, M D, Idle, J R, Ferner, R E
Publicado em 1990

Genetically determined oxidation capacity and the disposition of debrisoquine.

Por Sloan, T P, Lancaster, R, Shah, R R, Idle, J R, Smith, R L
Publicado em 1983

Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Por Mitchell, S C, Waring, R H, Haley, C S, Idle, J R, Smith, R L
Publicado em 1984

The genetic control of phenformin 4-hydroxylation.

Por Shah, R R, Evans, D A, Oates, N S, Idle, J R, Smith, R L
Publicado em 1985

The N-oxidation of trimethylamine in a Jordanian population.

Por Hadidi, H F, Cholerton, S, Atkinson, S, Irshaid, Y M, Rawashdeh, N M, Idle, J R
Publicado em 1995

Impaired oxidation of debrisoquine in patients with perhexiline neuropathy.

Por Shah, R R, Oates, N S, Idle, J R, Smith, R L, Lockhart, J D
Publicado em 1982

Polymorphic hydroxylation of debrisoquine in Ghanaians [proceedings]

Por Andoh, B., Idle, J. R., Mahgoub, A., Sloan, T. P., Smith, R. L., Woolhouse, N.
Publicado em 1979

The contribution of genetically determined oxidation status to inter-individual variation in phenacetin disposition.

Por Devonshire, H W, Kong, I, Cooper, M, Sloan, T P, Idle, J R, Smith, R L
Publicado em 1983

Drug points: Cyclosporin decreases nifedipine metabolism

Por McFadden, J P, Pontin, J E, Powles, A V, Fry, L, Idle, J R
Publicado em 1989